- Home
- NDLS vs HBIO Comparison
NDLS vs HBIO Comparison
Compare NDLS & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- HBIO
- Stock Information
- Founded
- NDLS 1995
- HBIO 1901
- Country
- NDLS United States
- HBIO United States
- Employees
- NDLS N/A
- HBIO N/A
- Industry
- NDLS Restaurants
- HBIO Biotechnology: Laboratory Analytical Instruments
- Sector
- NDLS Consumer Discretionary
- HBIO Industrials
- Exchange
- NDLS Nasdaq
- HBIO Nasdaq
- Market Cap
- NDLS 29.8M
- HBIO 24.6M
- IPO Year
- NDLS 2013
- HBIO 2000
- Fundamental
- Price
- NDLS $0.62
- HBIO $0.38
- Analyst Decision
- NDLS Buy
- HBIO Buy
- Analyst Count
- NDLS 2
- HBIO 3
- Target Price
- NDLS $3.00
- HBIO $2.50
- AVG Volume (30 Days)
- NDLS 124.1K
- HBIO 567.9K
- Earning Date
- NDLS 11-05-2025
- HBIO 11-06-2025
- Dividend Yield
- NDLS N/A
- HBIO N/A
- EPS Growth
- NDLS N/A
- HBIO N/A
- EPS
- NDLS N/A
- HBIO N/A
- Revenue
- NDLS $494,752,000.00
- HBIO $88,750,000.00
- Revenue This Year
- NDLS $1.19
- HBIO N/A
- Revenue Next Year
- NDLS N/A
- HBIO $7.02
- P/E Ratio
- NDLS N/A
- HBIO N/A
- Revenue Growth
- NDLS N/A
- HBIO N/A
- 52 Week Low
- NDLS $0.55
- HBIO $0.28
- 52 Week High
- NDLS $1.74
- HBIO $2.82
- Technical
- Relative Strength Index (RSI)
- NDLS 41.44
- HBIO 30.04
- Support Level
- NDLS $0.61
- HBIO $0.41
- Resistance Level
- NDLS $0.69
- HBIO $0.44
- Average True Range (ATR)
- NDLS 0.04
- HBIO 0.02
- MACD
- NDLS 0.01
- HBIO -0.00
- Stochastic Oscillator
- NDLS 16.09
- HBIO 1.75
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About HBIO Harvard Bioscience Inc.
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.